J. Carl Barrett, PhD

Dr. Barrett brings over three decades of experience in translational research to Corista as Chief Life Sciences Officer, leading biomarker development strategies using digital pathology. Prior to joining Corista, Dr. Barrett was Vice President of Translational Medicine and Oncology Biomarker Development in Oncology Research and Development at AstraZeneca. His responsibilities included developing and executing biomarker strategies and translational sciences efforts to support drug development. Dr. Barrett also served as the Global Head of Oncology Biomarkers and Imaging at Novartis Oncology Translational Medicine. He was the founding Director of the NCI Center for Cancer Research (CCR), which is part of the NCI Intramural Center for Translational Medicine and Novel Technologies.

Dr. Barrett received his Ph.D. in Biophysical Chemistry from Johns Hopkins University. He has published over 600 research articles and reviews in leading scientific journals and books, and is a member of the Johns Hopkins University Society of Scholars, an elected member of the Ramazini Foundation, and an honorary member of the Japanese Cancer Association, and a Distinguished Professor at the University of North Carolina, Chapel Hill.